We are live on ! Find out more
CVS icon

CVS Health

1,419 hedge funds and large institutions have $92.4B invested in CVS Health in 2014 Q4 according to their latest regulatory filings, with 184 funds opening new positions, 490 increasing their positions, 601 reducing their positions, and 42 closing their positions.

New
Increased
Maintained
Reduced
Closed

338% more first-time investments, than exits

New positions opened: 184 | Existing positions closed: 42

44% more funds holding in top 10

Funds holding in top 10: 140201 (+61)

20% more capital invested

Capital invested by funds: $77.1B → $92.4B (+$15.3B)

10% more funds holding

Funds holding: 1,2921,419 (+127)

0.04% more ownership

Funds ownership: 83.87%83.91% (+0.04%)

3% less call options, than puts

Call options by funds: $406M | Put options by funds: $419M

18% less repeat investments, than reductions

Existing positions increased: 490 | Existing positions reduced: 601

Holders
1,419
Holders Change
+127
Holders Change %
+9.83%
% of All Funds
37.83%
Holding in Top 10
201
Holding in Top 10 Change
+61
Holding in Top 10 Change %
+43.57%
% of All Funds
5.36%
New
184
Increased
490
Reduced
601
Closed
42
Calls
$406M
Puts
$419M
Net Calls
-$12.7M
Net Calls Change
-$2.29M
Name Holding Trade Value Shares
Change
Change in
Stake
VC
401
Vestor Capital
Illinois
$12.3M -$184K -2,090 -2%
AIM
402
Allen Investment Management
New York
$12.3M
KPCM
403
Kings Point Capital Management
New York
$12.3M +$126K +1,429 +1%
CTA
404
Chesley Taft & Associates
Illinois
$12.2M +$123K +1,400 +1%
MA
405
MUFG Americas
New York
$12.2M -$351K -3,978 -3%
MNA
406
Manning & Napier Advisors
New York
$12.1M +$390K +4,426 +4%
FAB
407
First American Bank
Illinois
$12M +$50.8K +577 +0.5%
BKBG
408
BHF Kleinwort Benson Group
Belgium
$11.9M -$75.8K -860 -0.7%
MOACM
409
Mutual of America Capital Management
New York
$11.9M -$54.8K -622 -0.5%
Brown Advisory
410
Brown Advisory
Maryland
$11.9M +$409K +4,644 +4%
FP
411
Foundry Partners
Minnesota
$11.8M -$949K -10,775 -8%
SM
412
Stratton Management
Pennsylvania
$11.7M +$1.4M +15,844 +15%
ERIM
413
Eagle Ridge Investment Management
Connecticut
$11.7M -$9.69K -110 -0.1%
OA
414
OFI Advisors
Pennsylvania
$11.6M -$456K -5,179 -4%
CCM
415
Covington Capital Management
California
$11.6M -$163K -1,846 -2%
CIBC World Market
416
CIBC World Market
Ontario, Canada
$11.4M +$1.61M +18,310 +18%
EAM
417
EverPoint Asset Management
Connecticut
$11.4M +$4.67M +53,000 +82%
LS
418
Livforsakringsbolaget Skandia
Sweden
$11.3M -$3.57M -40,500 -26%
WT
419
Whittier Trust
California
$11.3M +$14.4K +163 +0.1%
VCM
420
Violich Capital Management
California
$11.3M +$135K +1,535 +1%
LBC
421
Lowe Brockenbrough & Co
Virginia
$11.3M -$664K -7,531 -6%
NI
422
Numeric Investors
Massachusetts
$11.2M +$10.2M +116,100 New
MMH
423
Menora Mivtachim Holdings
Israel
$11.2M -$8.19M -92,950 -44%
Connor, Clark & Lunn Investment Management (CC&L)
424
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$11.2M -$2.92M -33,100 -22%
AT
425
AMF Tjänstepension
Sweden
$11.1M +$10.1M +114,743 New

CVS Hedge Fund Activity: Q4 2014 in Review

1,419 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in CVS Health (CVS) for Q4 2014, worth a combined $92.4B — up 20% from $77.1B a quarter earlier.

Buyers outnumbered sellers: 184 funds opened new CVS positions and 42 closed out — a net gain of 142 holders — while 490 added to existing stakes and 601 trimmed.

The largest buyer was Capital World Investors, adding an estimated $340M. The largest seller was Institutional Capital, exiting entirely with an estimated $373M sold.

  • 1,419 institutional investors held CVS Health (CVS) as of Q4 2014, up from 1,292 in Q3 2014.
  • Funds reported $92.4B of CVS Health stock for Q4 2014, up 20% quarter-over-quarter.
  • 184 funds opened new CVS Health positions in Q4 2014 and 42 closed out, a net change of +142 holders.
  • The largest CVS Health buyer in Q4 2014 was Capital World Investors, an estimated $340M added.
  • The largest CVS Health seller in Q4 2014 was Institutional Capital, an estimated $373M sold.

Based on aggregated 13F filings for Q4 2014.